Jump to main content
Jump to site search


Ameliorative role of camel whey protein and rosuvastatin on induced dyslipidemia in mice

Author affiliations

Abstract

The incidence of obesity is rapidly increasing throughout the world. Dyslipidemia is a major risk factor for a number of chronic diseases, including diabetes and cardiovascular diseases. This work presents a novel approach to study the activity of camel whey protein (WP) with antioxidant and anti-inflammatory properties as a cheap dietary protein substance extracted from camel milk to produce satiety and help in building muscles. Mice model suffering from dyslipidemia as a result of feeding on high fat-cholesterol diet for 8 weeks were administrated with either camel WP and/or rosuvastatin for 4 weeks. Dyslipidemia revealed significant increase in anthropometrical measurements, levels of glucose, insulin, cholesterol, triglycerides, low-density lipoprotein, total leucocyte count, inflammatory cytokines and reactive oxygen species, accompanied by a significant elevation in activating transcription factor-3 and inducible nitric oxide synthase expressions. These alterations were correlated with a profound reduction in high-density lipoprotein, peroxisome proliferator-activated receptor alpha and adiponectin along with a decrease in liver and muscle mitochondrial proteins. Rosuvastatin treatment to mice suffering from dyslipidemia in combination with camel WP for 4 weeks ameliorated these parameters. Notably, animals treated with both camel WP and rosuvastatin exhibited a remarkable decrease in the incidence of dyslipidemia. In addition, camel WP succeeded to overcome the therapeutic drawback posed from rosuvastatin therapy alone with minimal side effects.

Graphical abstract: Ameliorative role of camel whey protein and rosuvastatin on induced dyslipidemia in mice

Back to tab navigation

Publication details

The article was received on 25 Nov 2017, accepted on 02 Jan 2018 and first published on 02 Jan 2018


Article type: Paper
DOI: 10.1039/C7FO01871A
Citation: Food Funct., 2018, Advance Article
  •   Request permissions

    Ameliorative role of camel whey protein and rosuvastatin on induced dyslipidemia in mice

    N. A. El-Shinnawy, S. S. Abd Elhalem, N. Z. Haggag and G. Badr, Food Funct., 2018, Advance Article , DOI: 10.1039/C7FO01871A

Search articles by author

Spotlight

Advertisements